Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases

Radiotherapy and Oncology

Volumn 114, Issue 2, 2015, Pages 155-160

  Fode, Mette Marie ^a   Høyer, Morten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Oligo metastases; Prognostic factors; Stereotactic body radiotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; DISTANT METASTASIS; DYSPNEA; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; INOPERABLE CANCER; LIVER FAILURE; LOCAL THERAPY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; METASTASIS; OLIGO METASTASIS; OVERALL SURVIVAL; OXYGEN SUPPLY; PALLIATIVE THERAPY; PATIENT REFERRAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED RIB FRACTURE; RADIATION INJURY; RADIOTHERAPY PLANNING SYSTEM; RADIOTHERAPY UNIT; RIB FRACTURE; SKIN MANIFESTATION; STEREOTACTIC BODY RADIATION THERAPY; STOMACH FISTULA; SURVIVAL RATE; ADVERSE EFFECTS; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDY; SECONDARY; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926222348     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.12.003     Document Type: Article

References (33)

1. S. Hellman, and R.R. Weichselbaum Oligometastases J Clin Oncol 13 1995 8 10
2. A. Andres, P.E. Majno, and P. Morel Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score Ann Surg Oncol 15 2008 134 143
3. A.C. Wei, P.D. Greig, D. Grant, B. Taylor, B. Langer, and S. Gallinger Survival after hepatic resection for colorectal metastases: a 10-year experience Ann Surg Oncol 13 2006 668 676
4. M.G. House, H. Ito, and M. Gonen Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution J Am Coll Surg 210 2010 752 755
5. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318 [discussion 318-21]
6. M. Rees, P.P. Tekkis, F.K. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 2008 125 135
7. K.S. Corbin, S. Hellman, and R.R. Weichselbaum Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy J Clin Oncol 31 2013 1384 1390
8. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997;113:37-49.
9. G.D. Dodd 3rd, M.C. Soulen, and R.A. Kane Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough Radiographics 20 2000 9 27
10. M.E. Pijl, A.S. Chaoui, R.L. Wahl, and J.A. van Oostayen Radiology of colorectal cancer Eur J Cancer 38 2002 887 898
11. R.D. Timmerman, C.S. Bizekis, and H.I. Pass Local surgical, ablative, and radiation treatment of metastases CA Cancer J Clin 59 2009 145 170
12. M. Hoyer, A. Swaminath, and S. Bydder Radiotherapy for liver metastases: a review of evidence Int J Radiat Oncol Biol Phys 82 2012 1047 1057
13. S.S. Lo, B.S. Teh, and N.A. Mayr Stereotactic body radiation therapy for oligometastases Discov Med 10 2010 247 254
14. J. Widder, T.J. Klinkenberg, J.F. Ubbels, E.M. Wiegman, H.J. Groen, and J.A. Langendijk Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 107 2013 409 413
15. M. Hoyer, H. Roed, and A. Traberg Hansen Phase II study on stereotactic body radiotherapy of colorectal metastases Acta Oncol 45 2006 823 830
16. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Hoyer Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
17. E.S. Worm, A.T. Hansen, J.B. Petersen, L.P. Muren, L.H. Praestegaard, and M. Hoyer Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung Acta Oncol 49 2010 1177 1183
18. H. Blomgren, I. Lax, I. Naslund, and R. Svanstrom Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients Acta Oncol 34 1995 861 870
19. C.C. Pan, B.D. Kavanagh, and L.A. Dawson Radiation-associated liver injury Int J Radiat Oncol Biol Phys 76 2010 S94 100
20. World Health Organization. WHO handbook for reporting results of cancer treatment. http://whqlibdoc.who.int/offset/WHO-OFFSET-48.pdf.
21. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
22. M.T. Lee, J.J. Kim, and R. Dinniwell Phase I study of individualized stereotactic body radiotherapy of liver metastases J Clin Oncol 27 2009 1585 1591
23. R. McCammon, T.E. Schefter, L.E. Gaspar, R. Zaemisch, D. Gravdahl, and B. Kavanagh Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 2009 112 118
24. S. Siva, M.P. MacManus, R.F. Martin, and O.A. Martin Abscopal effects of radiation therapy: a clinical review for the radiobiologist Cancer Lett 356 2015 82 90
25. M.A. Postow, M.K. Callahan, and C.A. Barker Immunologic correlates of the abscopal effect in a patient with melanoma N Engl J Med 366 2012 925 931
26. D.A. Palma, J.K. Salama, and S.S. Lo The oligometastatic state-separating truth from wishful thinking Nat Rev Clin Oncol 11 2014 549 557
27. R. Adam, L. Chiche, and T. Aloia Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model Ann Surg 244 2006 524 535
28. M.T. Milano, A.W. Katz, H. Zhang, and P. Okunieff Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study Int J Radiat Oncol Biol Phys 83 2012 878 886
29. K.E. Rusthoven, B.D. Kavanagh, and H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
30. S.H. Bae, M.S. Kim, and C.K. Cho High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases J Surg Oncol 106 2012 138 143
31. M.A. Kress, B.T. Collins, S.P. Collins, A. Dritschilo, G. Gagnon, and K. Unger Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors Radiat Oncol 7 2012 148 10.1186/1748-717X-7-148
32. J.K. Salama, M.D. Hasselle, and S.J. Chmura Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease Cancer 118 2012 2962 2970
33. A. Takeda, E. Kunieda, T. Ohashi, Y. Aoki, N. Koike, and T. Takeda Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer Radiother Oncol 101 2011 255 259